Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Revert L is active.

Publication


Featured researches published by Revert L.


Digestive Diseases and Sciences | 1976

Prognostic value of spontaneous hyponatremia in cirrhosis with ascites

Vicente Arroyo; Juan Rodés; Miguel A. Gutiérrez-Lizárraga; Revert L

AbstractSpontaneous hyponatremia in cirrhosis with ascites is generally considered to be due to an impaired renal ability to excrete free water, to be a contraindication of diuretics, and to be a bad prognostic sign. These concepts are reviewed in this paper. 55 cirrhotics with ascites were divided into three groups. Group I consisted of 13 patients with hyponatremia and very low free-water clearance (


British Journal of Haematology | 1995

Patients with multiple myeloma requiring long-term dialysis: presenting features, response to therapy, and outcome in a series of 20 cases

R. Torra; Joan Bladé; Aleix Cases; J. López-Pedret; Emilio Montserrat; C. Rozman; Revert L


American Journal of Nephrology | 1990

Systemic involvement of dialysis-amyloidosis

Josep M. Campistol; Manel Solé; J. Muñoz-Gómez; José López-Pedret; Revert L

C_{H_2 O}


American Journal of Nephrology | 1990

End-Stage Renal Disease in Systemic Amyloidosis: Clinical Course and Outcome on Dialysis

Alberto Martinez-Vea; Carmen García; Montse Carreras; Revert L; Jesés Angel Oliver


American Journal of Nephrology | 1987

Visceral Involvement of Dialysis Amyloidosis

Josep M. Campistol; Aleix Cases; Albert Torras; Manuel Soler; Josep Muñoz-Gómez; Jesús Montoliu; Josep López-Pedret; Revert L

, 0.07±0.26 ml/min). These patients also had poor renal function: low inulin clearance (CINU, 40.6±25.9 ml/min) and paraamino-hippurate clearance (CPAH, 383±275 ml/min). Group II consisted of 8 patients who also had hyponatremia.


American Journal of Kidney Diseases | 1985

Lethal Hyperkalemia Associated With Severe Hyperglycemia in Diabetic Patients With Renal Failure

Jesús Montoliu; Revert L


Journal of Bone and Joint Surgery, American Volume | 1990

Pathological fractures in patients who have amyloidosis associated with dialysis. A report of five cases.

Josep M. Campistol; Manel Solé; J. Muñoz-Gómez; Josep Riba; R Ramón; Revert L

C_{H_2 O}


Journal of Internal Medicine | 1990

Treatment of hyperkalaemia in renal failure with salbutamol inhalation

J. Montoliu; J. Almirall; E. Ponz; J. M. Campistol; Revert L


Nephron | 1990

Ocular and Auditory Toxicity in Hemodialyzed Patients Receiving Desferrioxamine

Aleix Cases; Kelly J; Sabater F; Albert Torras; Griño Mc; Lopez-Pedret J; Revert L

, CINU, and CPAH in these patients were fairly high: 5.85±1.53 ml/min, 85.7±26.2 ml/min, and 651±294 ml/min. These values are similar to those of the 34 patients without hyponatremia who make up Group III: (6.37±4.27 ml/min, 94.7±33.1 ml/min, and 598±199 ml/min). Hyponatremia in Group I could be related to the impaired free-water clearance. The mechanism of hyponatremia in Group II patients is not clear. Patients with hyponatremia and low CINU and CPAH had a negative response to diuretics and a poor prognosis. Patients with hyponatremia but with relatively good renal function had a good prognosis, similar to Group III patients. They responded to diuretics with no worsening of their hyponatremia.


American Journal of Hypertension | 1998

Angiotensinogen gene M235T and T174M polymorphisms in essential hypertension: relation with target organ damage.

Patricia Fernández-Llama; Esteban Poch; Josep Oriola; Albert Botey; Francisca Rivera; Revert L

Summary. From January 1982 to December 1993, 30 patients with multiple myeloma (MM) required haemodialysis (HD) at our institution. The subgroup of 20 patients who survived more than 2 months on HD is the subject of this study. Four patients were already on HD, due to previous nephropathy, when MM was diagnosed. 13 patients presented with acute renal failure and were on dialysis from the time of diagnosis. The remaining three cases developed renal failure later in the course of the disease. The objective response rate was 40% (8/20). Only two patients could discontinue HD (one had a late partial recovery and one received a kidney graft). Mean hospitalization per year was 19.3 d. The subgroup of patients who survived < 1 year spent a mean of 38.3 d in hospital. Whereas in the subgroup with a survival > 1 year mean hospitalization days was 9.6 (P < 0.001). The median survival was 20 months and six patients survived for > 3 years. In summary, patients with MM and severe renal failure who survive the first 2 months on dialysis have an objective response rate to chemotherapy of 40% and a median survival of almost 2 years, with 30% long‐term survivors.

Collaboration


Dive into the Revert L's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Albert Botey

University of Barcelona

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Aleix Cases

University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Esteban Poch

University of Barcelona

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge